---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278150672.md"
description: "Gevo shares are trading higher after the company reported better-than-expected Q4 EPS results."
datetime: "2026-03-06T17:31:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278150672.md)
  - [en](https://longbridge.com/en/news/278150672.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278150672.md)
---

# 

Gevo shares are trading higher after the company reported better-than-expected Q4 EPS results.

### Related Stocks

- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [GEVO.US](https://longbridge.com/en/quote/GEVO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [GEVX.US](https://longbridge.com/en/quote/GEVX.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Gevo withdraws from DoE loan program, will seek alternative funding for ATJ-30 project](https://longbridge.com/en/news/282905074.md)
- [Gevo Withdraws Financing Application With Department of Energy](https://longbridge.com/en/news/282904482.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md)
- [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)